Sichenzia Ross Ference LLP Represents H.C. Wainwright as Sales Agent in $7 Million At-The-Market Offering of BioPath Holdings
Press Release – New York, NY – July 15, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC, as sales agent in an At-The-Market Offering (“ATM”) of BioPath Holdings Inc (NASDAQ: “BPTH”) common stock for gross proceeds of approximately $7 million. The shares were registered on BPTH’s Registration Statement on Form S-3 (File No. 333-231537) filed with the Securities and Exchange Commission on May 16, 2019, and declared effective by the SEC on June 5, 2019, and the prospectus supplement relating to the ATM filed with the SEC on July 14, 2020.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, and Avital Perlman, and associate Jacob Tabman.
- Sichenzia Ross Ference LLP Represents Borqs Technologies, Inc. in $20 Million Private Placement - March 3, 2021
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.5 Million Underwritten Public Offering of American Depositary Shares of Medigus Ltd. - March 3, 2021
- Sichenzia Ross Ference LLP Represents SunHydrogen in $10.0 Million Registered Direct Offering - March 3, 2021